Beckman Coulter Genomics Partners with GENpathway Inc. to Offer Comprehensive ChIP-Seq Solutions

Beckaman Coulter -- DANVERS, Mass., and SAN DIEGO (February 2, 2010) – Beckman Coulter Genomics Inc., and Genpathway, Inc., today announced a strategic partnership to offer customers whole-genome chromatin immunoprecipitation sequencing (ChIP-Seq) services. The alliance provides researchers investigating gene regulation and genetic pathways a single, inclusive source for services supporting genome-wide studies of transcription factor binding, gene transcription and epigenetic events.